Friday, January 28, 2022: Payers

The CMS announced $49.4 million in grant funding to shore up enrollment and retention in Medicaid and the Children’s Health Insurance Program among parents, pregnant people, and children. The funding will go to state and local governments, tribal organizations,...

Friday, January 28, 2022: Life Sciences

Merck & Co. Inc. and Ridgeback Biotherapeutics LP said their COVID-19 antiviral pill, molnupiravir, was active against the Omicron variant in six lab studies. The drug’s effectiveness against Omicron hasn’t yet been studied in human trials. (Article...

Friday, January 28, 2022: Life Sciences

Biogen Inc. will sell its nearly 50 percent stake in Samsung Bioepis, a joint venture with Samsung Biologics to develop biosimilar drugs, to its partner for at least $2.25 billion. The deal will give Biogen access to $1 billion in cash upon closing as the pharma...

Thursday, January 27, 2022: Payers

During a recent webinar, Third Horizon Strategies Managing Director Cheryl Matochik discussed what the employee benefits industry can expect to see in 2022. Cheryl stated that the industry is “moving toward a completely new standard of personalized benefits.” She, and...